NasdaqHealth CareBiological Products, (No Diagnostic Substances)WARREN, NJ

Tevogen Inc. TVGN

Ask your AI

Estimated market cap $39.07M6.51M shares, shares as of Aug 10, 2026CIK 1860871

Insider trades, 12 mo

0 buys · 3 sells

$6,635 sold, open market

Congress trades, 24 mo

—

No disclosed trades

13F holders, Q3 2026

0.7% of shares · 1 added

13F holders

…

Lobbying, 12 mo

—

No lobbying filings

Federal contracts, 12 mo

—

None matched

Ask your AI:

Latest 10-Q

Q2 2026

What changed in Tevogen Inc.'s latest quarterly report, compared with the one before.

Filed Aug 14, 2026 · Quarter ended Jun 30, 2026

AI No AI summary for this 10-Q: the draft did not pass our accuracy checks.

Compared with the 10-Q for the quarter ended Mar 31, 2026. Sections compared: management's discussion, risk factors, legal proceedings and controls and procedures.

Read the 10-Q on sec.gov ↗Filing index ↗

Latest 10-Q

What changed in Tevogen Inc.'s latest quarterly report, compared with the one before.

Loading…

Insider trades

3 in 12 mo

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

No open-market insider trades reported since Mar 13, 2026. Insiders have two business days to file.

Recent insider trades

Neal Flomenberg See Remarks	Mar 13 Form 4 ↗	Sale	−$3,206 501 sh @ $6.40	-2.4%
Neal Flomenberg See Remarks	Mar 11 Form 4 ↗	Sale	−$3,282 452 sh @ $7.26	-31.3%
Neal Flomenberg See Remarks	Mar 10 Form 4 ↗	Sale	−$147 19 sh @ $7.75	-34.4%
Ryan H. Saadi Chief Executive Officer, Director, 10% owner	Jun 9, 2025 Form 4 ↗	Sale	−$1.8M 1.44M sh @ $1.23	-114.9%
Neal Flomenberg See Remarks	Mar 12, 2025 Form 4 ↗	Sale	−$253.9K 232,968 sh @ $1.09	-124.2%

All TVGN insider trades →Planned sales (Form 144): see notices

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

Loading…

13F holders

45,925 shares

16 funds report TVGN. Values checked against market prices.

Funds own 1.7% of shares (Q2 2026)

31 funds hold the stock.

Q3 2026: 0.7% · 5,560 of ~8,900 funds reported so far

Q1 20263.3%
Q2 20261.7%
Q3 2026 (so far)0.7%

Q3 2026. 2 new, 1 added to, 10 trimmed, 17 exited since Q2 2026.

Top 13F holders
#
1	Vanguard Capital Management LLC 13F ↗	16,941	$112.1K	-29.3%
2	Geode Capital Management, LLC 13F ↗	11,619	$76.9K	New
3	Vanguard Fiduciary Trust Co 13F ↗	7,515	$49.7K	+796.8%
4	Morgan Stanley 13F ↗	4,695	$31.1K	-75.0%
5	Russell Investments Group, Ltd. 13F ↗	3,850	$25.5K	-41.1%
6	FMR LLC 13F ↗	831	$5,501	-91.5%
7	UBS Group AG 13F ↗	149	$986	-86.2%
8	BNP Paribas Financial Markets 13F ↗	121	$801	unchanged
9	JPMorgan Chase & Co 13F ↗	112	$756	-71.5%
10	Allworth Financial LP 13F ↗	50	$283	unchanged

Download CSV Every fund that holds TVGN, not only these ten. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

13F holders

Funds that report this stock, checked against market prices.

Loading…

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

No recent congressional trades for this company.

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

Loading…

Lobbying

What Tevogen Inc. and its lobbying firms report each quarter.

No recent lobbying filings for this company.

Lobbying

What Tevogen Inc. and its lobbying firms report each quarter.

Loading…

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Funds holding the stock

Shares they report

Funds holding the stock by quarter

Q1 2026	30	—	135,825	$614.1K
Q2 2026	31	+1	107,503	$608.7K
Q3 2026	16	-15	45,925	$304.0K

Each point is a quarter-end, from Q1 2026 to Q3 2026. A fund's 13F lists its long positions in US-listed securities as of the last day of the quarter and arrives up to 45 days later, so each point shows holdings at quarter-end, not on the day they were reported.

Common shares only; options and bonds are left out. When a fund amends a report, the amended version is the one counted.

The history follows the company's current CUSIP number (88165K200). If the company's shares were ever re-issued under a different CUSIP, the quarters before the change are not part of this series, so the first point (Q1 2026) can be later than the stock's first appearance in 13F reports.

Share counts are adjusted for stock splits; none took place between these quarters. Values are in dollars as reported at the time and are not adjusted.

A quarter appears once our daily update has built its summary. If a summary cannot be built, older reports are kept and the chart shows the quarters it has until the next update repairs it.

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Loading…

More filings and data

Each opens the table.

Ownership stakes5 in 12 mo 8-K events6 in 90 days PatentsNone on record Short interestFINRA · updated Oct 15 Planned insider salesForm 144 · 2 in 12 mo Executive payNone on record Wikipedia attentionNone on record SEC enforcementNone on record IPO history2 registrations Ownership stakes…8-K events…Patents…Short interest…Planned insider sales…Executive pay…Wikipedia attention…SEC enforcement…

About the company

The basics from the company’s SEC registration.

Legal name: Tevogen Inc.
Address: 15 INDEPENDENCE BOULEVARD, SUITE #210, WARREN, NJ 07059
Phone: 646-807-8832
Fiscal year ends: Dec 31
Filer category: emerging growth company
Incorporated in: DE
Listed as: TVGN (Nasdaq), TVGNW (Nasdaq)
Former names: Tevogen Bio Holdings Inc. (until 2026); Semper Paratus Acquisition Corp (until 2024)
SEC filings: All filings on SEC EDGAR ↗

About the company

The basics from the company’s SEC registration.

Loading…

$6.00+$0.28 (+4.90%) Nov 13 close

1M3M1Y

Oct 13, 2026Low $5.56 · High $7.11Nov 13, 2026

Aug 13, 2026Low $5.56 · High $7.85Nov 13, 2026

Nov 13, 2025Low $3.89 · High $24.05Nov 13, 2026

Congress purchase Congress sale Insider sale over $1M

Adjusted for stock splits; not for dividends. The stock split 1-for-50 on Mar 6, 2026; earlier prices are shown divided by the split ratio. Where prices come from.

Live chart

Intraday and historical prices from TradingView. Quotes may be delayed.

Loading chart…

Information, not investment advice. Company matching is automatic; check the source before relying on one row.